News

Filter

Current filters:

DepomedNovartis

Mylan debuts Lescol copy; Impax challenges Gralise patent

16-04-2012

US generic drug major Mylan (Nasdaq: MYL) revealed last Friday that it has begun shipping its generic…

Cardio-vascularDepomedGenericsGraliseImpax LaboratoriesLescolMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsRegulation

US FDA clears use of Novartis’ Menveo for over two-year-olds; Depomed leaps on approval of shingles drug Gralise

31-01-2011

The US Food and Drug Administration has approved Swiss drug major Novartis’ (NOVN: VX) Menveo (meningococcal…

Abbott LaboratoriesDepomedGraliseMenveoNeurologicalNorth AmericaNovartisPharmaceuticalRegulationVaccines

COMPANY SPOTLIGHT

Menarini

Back to top